Reset filters
  • 27 June 2012

Second-line HIV therapy effective and durable in South Africa, and adherence support could improve rates of viral suppression

Read the article
  • 8 June 2012

Big delays in switching to second-line ART in South Africa

Read the article
  • 24 April 2012

Treatment switches becoming less common, side-effects still the key reason for switching

Read the article
  • 8 March 2012

When does viral load testing add value in sub-Saharan Africa?

Read the article
  • 24 February 2012

Second-line treatment failure most often due to poor adherence in low and middle-income countries

Read the article
  • 9 December 2011

Treatment switches after CD4 count decline reduce risk of death by 75% in Zambia, Malawi

Read the article
  • 18 October 2011

Switching from efavirenz to rilpivirine single tablet is safe and effective

Read the article
  • 20 September 2011

Switching to once-daily etravirine a safe and effective option for individuals taking suppressive protease inhibitor therapy

Read the article
  • 19 September 2011

A fifth of patients discontinue Atripla within a year, CNS side-effects the main reason

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.